Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Noura M Al-Mutairi"'
Publikováno v:
PLoS ONE, Vol 17, Iss 10, p e0276487 (2022)
Early detection of Mycobacterium tuberculosis (Mtb) in clinical specimens, its susceptibility to anti-TB drugs and disruption of infection transmission to new hosts are essential components for global tuberculosis (TB) control efforts. This study inv
Externí odkaz:
https://doaj.org/article/5bff4f59a6ce4f889179c77e42ceaf8b
Publikováno v:
European Journal of Medical Research, Vol 25, Iss 1, Pp 1-5 (2020)
The original publication of this article [1] contained few erroneous paragraphs and errors in Table 1 and Table 2. The first four paragraphs are in the ‘Results’ section while the last four paragraphs are in the ‘Discussion’ section. The erro
Externí odkaz:
https://doaj.org/article/907a2ef9966442b590bea5f922e45ae2
Publikováno v:
BMC Infectious Diseases, Vol 19, Iss 1, Pp 1-9 (2019)
Abstract Background Accurate drug susceptibility testing (DST) of Mycobacterium tuberculosis in clinical specimens and culture isolates to first-line drugs is crucial for diagnosis and management of multidrug-resistant tuberculosis (MDR-TB). Resistan
Externí odkaz:
https://doaj.org/article/e0af21945e1643c8a49c7ca714e8344e
Autor:
Husam Zaglul, Noura M Al-Mutairi, Ahad Al-Otaibi, Eiman Mokaddas, Hanaa S. Eldeen, Suhail Ahmad
Publikováno v:
Journal of Infection and Public Health, Vol 14, Iss 11, Pp 1612-1613 (2021)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3b45eff8a77011555b29690e3fb15a64
https://pubmed.ncbi.nlm.nih.gov/34624715
https://pubmed.ncbi.nlm.nih.gov/34624715
Publikováno v:
Scientific Reports
Scientific Reports, Vol 11, Iss 1, Pp 1-9 (2021)
Scientific Reports, Vol 11, Iss 1, Pp 1-9 (2021)
Molecular methods detect genetic mutations associated with drug resistance. This study detected resistance-conferring mutations in gyrA/gyrB for fluoroquinolones and rrs/eis genes for second-line injectable drugs (SLIDs) among multidrug-resistant Myc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fe4ab783e55b9e407bb85aa2d3a78698
http://europepmc.org/articles/PMC8032671
http://europepmc.org/articles/PMC8032671
Publikováno v:
European Journal of Medical Research, Vol 25, Iss 1, Pp 1-5 (2020)
Increasing incidence of multidrug-resistant Mycobacterium tuberculosis infections is hampering global tuberculosis control efforts. Kuwait is a low-tuberculosis-incidence country, and ~ 1% of M. tuberculosis strains are resistant to rifampicin and is
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d3e701f4067ce41fe779570b9a644d40
https://doi.org/10.1186/s40001-020-00412-7
https://doi.org/10.1186/s40001-020-00412-7
Publikováno v:
Microbial Drug Resistance. 24:923-931
Proper management of multidrug-resistant tuberculosis (MDR-TB) requires accurate drug susceptibility testing (DST) of Mycobacterium tuberculosis isolates to other (ethambutol [EMB], pyrazinamide, and streptomycin [SM]) first-line drugs. This study co
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7d15c759684a0f878baae424f705de52
https://doi.org/10.1089/mdr.2017.0294
https://doi.org/10.1089/mdr.2017.0294
Publikováno v:
European Journal of Medical Research
European Journal of Medical Research, Vol 24, Iss 1, Pp 1-13 (2019)
European Journal of Medical Research, Vol 24, Iss 1, Pp 1-13 (2019)
Background Increasing incidence of multidrug-resistant Mycobacterium tuberculosis infections is hampering global tuberculosis control efforts. Kuwait is a low-tuberculosis-incidence country, and ~ 1% of M. tuberculosis strains are resistant to rifamp
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::13ceb9f74cd8636bd1721b7ce3a20bc6
http://europepmc.org/articles/PMC6894303
http://europepmc.org/articles/PMC6894303
Publikováno v:
BMC Infectious Diseases
BMC Infectious Diseases, Vol 19, Iss 1, Pp 1-9 (2019)
BMC Infectious Diseases, Vol 19, Iss 1, Pp 1-9 (2019)
Background Accurate drug susceptibility testing (DST) of Mycobacterium tuberculosis in clinical specimens and culture isolates to first-line drugs is crucial for diagnosis and management of multidrug-resistant tuberculosis (MDR-TB). Resistance of M.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f7164c6fa73034725cc648f88c9e72ba
https://doi.org/10.1186/s12879-018-3638-z
https://doi.org/10.1186/s12879-018-3638-z
Publikováno v:
Expert review of anti-infective therapy. 16(9)
Prevalence of TB and MDR-TB varies considerably among various regions of World Health Organization (WHO) and also among individual countries within each region. Many Middle Eastern countries have war/civil war-like situations, refugees from war-torn
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::71f1983dca159faa6c14c55605c2230f
https://pubmed.ncbi.nlm.nih.gov/30173588
https://pubmed.ncbi.nlm.nih.gov/30173588